Skip to main content
NCBI home page
Gut logoLink to Gut
. 1988 Dec;29(12):1680–1686. doi: 10.1136/gut.29.12.1680

Hydrogen peroxide induced adenosine diphosphate ribosyl transferase (ADPRT) response in patients with inflammatory bowel disease.

M M Markowitz 1, P Rozen 1, R W Pero 1, M Tobi 1, D G Miller 1
PMCID: PMC1434093  PMID: 3146530

Abstract

The sample population in this initial case control study of the adenosine diphosphate ribosyl transferase (ADPRT) response of inflammatory bowel disease patients included: 23 patients with ulcerative colitis (UC)-active and inactive, 13 patients with Crohn's disease (CD)-active and inactive, 14 first degree relatives of UC and CD patients, and 19 age-matched controls. Adenosine diphosphate ribosyl transferase activity was determined after one hour incubation with 1% plasma (the constitutive value) or with 1% plasma and 100 microM H2O2 (the activated value) with the resulting difference designated as the induced value. Statistically significant decrease in ADPRT activity was found for the constitutive, activated and induced values in human mononuclear leucocytes of UC and CD patients, compared with controls. The values in the first degree relatives of UC and CD patients were not significantly different from either the control or disease populations, indicating an intermediate ADPRT response. These results may be related to the nature of the immunological response of IBD patients and comparable with similar findings in other diseases with known DNA repair deficiencies--for example, colon cancer.

Full text

PDF
1680

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alstead E. M., McConnell R. B. Genetic aspects of inflammatory bowel disease and gastrointestinal cancer. Acta Gastroenterol Belg. 1984 Mar-Apr;47(2):139–148. [PubMed] [Google Scholar]
  2. BROBERGER O., PERLMANN P. Autoantibodies in human ulcerative colitis. J Exp Med. 1959 Nov 1;110:657–674. doi: 10.1084/jem.110.5.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brahme F., Lindström C., Wenckert A. Crohn's disease in a defined population. An epidemiological study of incidence, prevalence, mortality, and secular trends in the city of Malmö, Sweden. Gastroenterology. 1975 Aug;69(2):342–351. [PubMed] [Google Scholar]
  4. Calabro J. J., Williamson P., Love E. S., Kostylo F., Jeghers H. Kawasaki syndrome. N Engl J Med. 1982 Jan 28;306(4):237–238. doi: 10.1056/NEJM198201283060412. [DOI] [PubMed] [Google Scholar]
  5. Calkins B. M., Lilienfeld A. M., Garland C. F., Mendeloff A. I. Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci. 1984 Oct;29(10):913–920. doi: 10.1007/BF01312480. [DOI] [PubMed] [Google Scholar]
  6. Elson C. O., Kagnoff M. F., Fiocchi C., Befus A. D., Targan S. Intestinal immunity and inflammation: recent progress. Gastroenterology. 1986 Sep;91(3):746–768. doi: 10.1016/0016-5085(86)90649-9. [DOI] [PubMed] [Google Scholar]
  7. Farzaneh F., Zalin R., Brill D., Shall S. DNA strand breaks and ADP-ribosyl transferase activation during cell differentiation. Nature. 1982 Nov 25;300(5890):362–366. doi: 10.1038/300362a0. [DOI] [PubMed] [Google Scholar]
  8. Fielding J. F. The relative risk of inflammatory bowel disease among parents and siblings of Crohn's disease patients. J Clin Gastroenterol. 1986 Dec;8(6):655–657. doi: 10.1097/00004836-198612000-00013. [DOI] [PubMed] [Google Scholar]
  9. Hamilton S. R. Colorectal carcinoma in patients with Crohn's disease. Gastroenterology. 1985 Aug;89(2):398–407. doi: 10.1016/0016-5085(85)90343-9. [DOI] [PubMed] [Google Scholar]
  10. Jewell D. P., Patel C. Immunology of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1985;114:119–126. doi: 10.3109/00365528509093772. [DOI] [PubMed] [Google Scholar]
  11. Johnstone A. P., Williams G. T. Role of DNA breaks and ADP-ribosyl transferase activity in eukaryotic differentiation demonstrated in human lymphocytes. Nature. 1982 Nov 25;300(5890):368–370. doi: 10.1038/300368a0. [DOI] [PubMed] [Google Scholar]
  12. Kemler B. J., Alpert E. Inflammatory bowel disease: study of cell mediated cytotoxicity for isolated human colonic epithelial cells. Gut. 1980 May;21(5):353–359. doi: 10.1136/gut.21.5.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kirsner J. B. Inflammatory bowel disease. Considerations of etiology and pathogenesis. Am J Gastroenterol. 1978 Mar;69(3 Pt 1):253–271. [PubMed] [Google Scholar]
  14. Kirsner J. B. The idiopathic' inflammatory bowel diseases: their cause and pathogenesis. Arch Dermatol. 1982 Apr;118(4):280–282. [PubMed] [Google Scholar]
  15. Lewkonia R. M., McConnell R. B. Progress report. Familial inflammatory bowel disease--heredity or environment? Gut. 1976 Mar;17(3):235–243. doi: 10.1136/gut.17.3.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Markowitz M. M., Johnson D. B., Pero R. W., Winawer S. J., Miller D. G. Effects of cumene hydroperoxide on adenosine diphosphate ribosyl transferase in mononuclear leukocytes of patients with adenomatous polyps in the colon. Carcinogenesis. 1988 Mar;9(3):349–355. doi: 10.1093/carcin/9.3.349. [DOI] [PubMed] [Google Scholar]
  17. Moody C. S., Hassan H. M. Mutagenicity of oxygen free radicals. Proc Natl Acad Sci U S A. 1982 May;79(9):2855–2859. doi: 10.1073/pnas.79.9.2855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Morgenstern R., Pero R. W., Miller D. G. Induction of unscheduled DNA synthesis in human mononuclear leukocytes by oxidative stress. Adv Exp Med Biol. 1986;197:819–823. doi: 10.1007/978-1-4684-5134-4_77. [DOI] [PubMed] [Google Scholar]
  19. Nielsen O. H., Ahnfelt-Rønne I., Elmgreen J. Abnormal metabolism of arachidonic acid in chronic inflammatory bowel disease: enhanced release of leucotriene B4 from activated neutrophils. Gut. 1987 Feb;28(2):181–185. doi: 10.1136/gut.28.2.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nishida T., Miwa H., Shigematsu A., Yamamoto M., Iida M., Fujishima M. Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis. Gut. 1987 Aug;28(8):1002–1007. doi: 10.1136/gut.28.8.1002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pero R. W., Bryngelsson C., Mitelman F., Thulin T., Nordén A. High blood pressure related to carcinogen-induced unscheduled DNA synthesis, DNA carcinogen binding, and chromosomal aberrations in human lymphocytes. Proc Natl Acad Sci U S A. 1976 Jul;73(7):2496–2500. doi: 10.1073/pnas.73.7.2496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pero R. W., Heim S., Bryngelsson C. Lower rates of thymidine incorporation into DNA of skin fibroblasts from patients with adenomatosis of the colon and rectum. Carcinogenesis. 1986 Apr;7(4):541–545. doi: 10.1093/carcin/7.4.541. [DOI] [PubMed] [Google Scholar]
  23. Pero R. W., Jonsson G. G., Persson L. Unscheduled DNA synthesis induced by N-acetoxy-2-acetylaminofluorene is not sensitive to regulation by ADP-ribosyl transferase. Chem Biol Interact. 1983 Dec;47(3):265–275. doi: 10.1016/0009-2797(83)90162-x. [DOI] [PubMed] [Google Scholar]
  24. Pero R. W., Miller D. G., Lipkin M., Markowitz M., Gupta S., Winawer S. J., Enker W., Good R. Reduced capacity for DNA repair synthesis in patients with or genetically predisposed to colorectal cancer. J Natl Cancer Inst. 1983 May;70(5):867–875. [PubMed] [Google Scholar]
  25. Pero R. W., Ritchie M., Winawer S. J., Markowitz M. M., Miller D. G. Unscheduled DNA synthesis in mononuclear leukocytes from patients with colorectal polyps. Cancer Res. 1985 Jul;45(7):3388–3391. [PubMed] [Google Scholar]
  26. Purnell M. R., Stone P. R., Whish W. J. ADP-ribosylation of nuclear proteins. Biochem Soc Trans. 1980 Apr;8(2):215–227. doi: 10.1042/bst0080215. [DOI] [PubMed] [Google Scholar]
  27. Schlosstein L., Terasaki P. I., Bluestone R., Pearson C. M. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 1973 Apr 5;288(14):704–706. doi: 10.1056/NEJM197304052881403. [DOI] [PubMed] [Google Scholar]
  28. Scovassi A. I., Stefanini M., Lagomarsini P., Izzo R., Bertazzoni U. Response of mammalian ADP-ribosyl transferase to lymphocyte stimulation, mutagen treatment and cell cycling. Carcinogenesis. 1987 Sep;8(9):1295–1300. doi: 10.1093/carcin/8.9.1295. [DOI] [PubMed] [Google Scholar]
  29. Setlow R. B. Repair deficient human disorders and cancer. Nature. 1978 Feb 23;271(5647):713–717. doi: 10.1038/271713a0. [DOI] [PubMed] [Google Scholar]
  30. Sharon P., Stenson W. F. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology. 1984 Mar;86(3):453–460. [PubMed] [Google Scholar]
  31. Strober W., James S. P. The immunologic basis of inflammatory bowel disease. J Clin Immunol. 1986 Nov;6(6):415–432. doi: 10.1007/BF00915248. [DOI] [PubMed] [Google Scholar]
  32. Troll W., Wiesner R. The role of oxygen radicals as a possible mechanism of tumor promotion. Annu Rev Pharmacol Toxicol. 1985;25:509–528. doi: 10.1146/annurev.pa.25.040185.002453. [DOI] [PubMed] [Google Scholar]
  33. Ueda K., Hayaishi O. ADP-ribosylation. Annu Rev Biochem. 1985;54:73–100. doi: 10.1146/annurev.bi.54.070185.000445. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES